predictive-ai
(6)
David Bradley Has Spent a Career Making Silos Talk
From turning ibm.com into a $12 billion sales channel to redirecting surplus produce toward families, the r4 executive has built a career around one stubborn idea: useful information should travel farther than the department that owns it.
Abraham Parangi
Abraham Parangi is the co-founder and co-CEO of Akkio, a Cambridge, Massachusetts AI company that builds no-code predictive and generative analytics for media agencies and businesses. A Cornell-trained computer scientist who has worked on everything from missile guidance systems to iPhone ad technology, Parangi co-founded Akkio in 2019 with the goal of putting machine learning in the hands of people who do not write code. The company has raised $18M, including a $15M Series A led by Bain Capital Ventures in 2023, and now powers AI media-planning systems used across the global advertising ecosystem.
Daniel Saks
Daniel Saks is the co-founder and CEO of Landbase, a San Francisco agentic-AI company building GTM-1 Omni, an action model purpose-built to automate B2B go-to-market work. He previously co-founded and co-led AppDirect, the subscription-commerce platform that became a unicorn. A Forbes 30 Under 30 honoree and McGill graduate, Saks traces his obsession with helping small businesses survive to his family's century-old furniture store in Niagara Falls, which closed during the Great Recession.
Jeff Elton
Jeff Elton, Ph.D., is the founding CEO and now Vice Chairman of ConcertAI, a Cambridge-based company building generative and predictive AI on the world's largest multi-modal oncology dataset. He grew the company from a 2017 startup into a roughly $1.9 billion business with about 1,300 employees, acquiring TeraRecon's imaging technology and ASCO's CancerLinQ network along the way. A former Accenture managing director, Novartis research COO, and McKinsey partner, he co-authored the widely cited book Healthcare Disrupted and chairs the MassBio board.
Severence MacLaughlin
Severence MacLaughlin is the founder and CEO of DeLorean Artificial Intelligence, a Palm Beach-based company building predictive AI products for healthcare and sales. A Cornell-trained scientist with a PhD from the University of Adelaide, he ran AI and data science practices at Cognizant and Capgemini Invent before bootstrapping DeLorean AI with his own savings. The company says its Medical AI was the first to be biologically validated by two independent laboratories, trained on tens of millions of patient records and backed by seven patents. He advises the United Nations and World Health Organization on AI.
Debanjan Saha
Debanjan Saha is the CEO of DataRobot, leading one of the most widely deployed enterprise AI platforms in the world. A PhD in Computer Science from the University of Maryland and alumnus of IIT Kharagpur, he built his career across IBM, Amazon Web Services (where he launched Amazon Aurora), and Google Cloud (where he oversaw BigQuery Omni and Dataplex). He joined DataRobot in February 2022, became interim CEO in July 2022, and was formally appointed CEO in September 2022. He holds 50+ patents, is an IEEE Fellow, and a Distinguished Member of the ACM.